A CLINCAL STUDY TO EVALUATE THE EFFICACY OF UTKLESHANA BASTI, DOSHAHARA BASTI AND LEKHANA BASTI IN THE MANAGEMENT OF SHAREERA ANUKRAMA ATISNEHA W.S.R. TO DYSLIPIDEMIA â?? A MULTIDIMENSIONAL APPROACH

CRITICAL EVALUATION ON THE EFFICACY OF LEKHANA BASTI IN THE MANAGEMENT OF SHAREERA ANUKRAMA ATISNEHA W.S.R. TO DYSLIPIDEMIA â?? A MULTIDIMENSIONAL APPROACH

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017138

Enrollment

120

Registered

2019-01-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

Intervention1: Randomized Comparative Clinical study: INTERVENTION AND COMPARATOR AGENT GROUP A - UTKLESHANA BASTI, DOSHAHARA BASTI AND LEKHANA BASTI. (IN THE PATTERN OF KALABASTI FOR A PERIOD OF FI

Eligibility

Inclusion criteria

Inclusion criteria: 1.PATIENTS HAVING ONE OR MORE OF THE DIAGNOSTIC CRITERIA OF DYSLIPIDEMIA. 2.PATIENTS FIT FOR BASTI KARMA, VAMANA KARMA AND UDWARTANA.

Exclusion criteria

Exclusion criteria: 1.PATIENTS WITH ANY OTHER DISEASES WHICH MAY INTERFERE WITH THE COURSE OF TREATMENT. 2.PATIENTS WITH ESSENTIAL HYPERTENSION. 3.PATIENTS UNFIT FOR BASTI KARMA, VAMANA KARMA AND UDWARTANA.

Design outcomes

Primary

Measure	Time frame
EFFECTIVE ACHIEVEMENT OF SAMYAK YOGA OF TREATMENT MODALITIESTimepoint: 45days	—

Secondary

Measure	Time frame
DESIRED CHANGES IN THE SEROLOGICAL INVESTIGATIONS.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Loashri S J

Rajiv Gandhi university of health sciences

kiranmgoud@yahoo.co.in9845109556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026